Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
The bulk drugs (API) segment contributed marginally over 60 per cent to the company’s total turnover in Q1 FY 2019-20. - THE HINDU
The government has approved the first set of five pharma projects, worth a total committed investment of ₹3,761 crore under the Production Linked Incentive (PLI) scheme for promoting domestic manufacture of bulk drugs and active pharmaceutical ingredients (APIs).
An official statement said on Friday that the projects relate to four fermentation-based key starting materials and APIs such as penicillin G, 7-ACA (7-aminocephalosporanic acid), erythromycin thiocyanate and clavulanic acid, which are all entirely imported now.
An expert committee set up by the Department of Pharmaceuticals in the Ministry of Chemicals and Fertilisers identified 53 APIs for which the country is mainly import dependent. These bulk drugs accounted for 63 per cent of the total pharmaceutical imports. Subsequently, an Empowered Committee headed by Amitabh Kant, CEO NITI Aayog, was set up last year to design the PLI scheme that could help India achieve drug security.
The Ministry of Chemicals and Fertilisers had called for applications for manufacturing 36 APIs and bulk drugs in four target segments under the PLI scheme till November 30. The total incentives earmarked for the scheme was ₹6,940 crore.
The current approval is for the first target segment and these projects, expected to commence production by April 2023, would get a maximum of ₹3,600 crore over the next six years. If the project meet the assigned production targets, they would get 20 per cent incentive for FY24 to FY27, 15 per cent for FY28 and 5 per cent FY29.
Aurobindo Pharma through its subsidiaries would launch projects for producing 15,000 tonne per annum (TPA) of Penicillin G, 2,000 TPA of 7-ACA and 1,600 TPA of erythromycin thiocyanate. Karnataka Antibiotics & Pharmaceuticals’ project for producing 1,000 TPA of 7-ACA and Kinvan Private Limited’s 300 TPA of clavulanic acid project have all been green-lighted.
“Setting up of these plants will make the country self-reliant to a large extent in these bulk drugs,” the Ministry statement said. The Ministry said it would approve applications in the other three categories over the next 45 days.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
This Women’s Day, we discuss the features of a few financial products that aim to help you save, get insured ...
Sensex, Nifty 50 make a strong bounce-back, but test resistances
Avenue Supermarts (₹3,286.1): Makes fresh all-time highIn October last year, the stock of Avenue Supermarts ...
The exchange-traded fund ticks all boxes as an efficient tool to track gold prices
A cop, a poet, a wedding planner, an outraged wife: On International Women’s Day, a look at diverse stories ...
India’s privacy law must balance the rights of children with online safety
Muriel has put our names down on a list to get the Covid-19 vaccination because — hurrah! — the age limit has ...
They are the health warriors who battled the Covid-19 pandemic on the ground, and are now the face of the ...
Comfort, convenience, value, safety — and not necessarily the colour pink — but do brands deliver?
Why and how marketers have used camels, and left us thirsting for more
Start-up SALT wants to break feminine stereotypes around money, and is asking women to reassert agency
It’s that time of year again when brands suddenly start paying obeisance to women power. From sentimental to ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor